Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion.
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
We recently demonstrated that sc administered interleukin-6 (IL-6) strongly stimulates the human hypothalamic-pituitary-adrenal (HPA) axis, with mild toxicity and no hypotensive effects. In this study, we evaluated the response of the human HPA axis to escalating iv doses of recombinant IL-6 in six patients with cancer and good performance status who received daily, every 8 h, three equal doses of 0.3-30 micrograms/kg IL-6. The plasma levels of IL-6 assayed by a specific enzyme-linked immunosorbent assay during the 4 h following the first IL-6 injection were elevated for 2-4 h, proportionally to the amount of injected IL-6. Administration of the cytokine was followed by marked elevations of plasma ACTH (53.0-98.6 pmol/L) and cortisol (824.9-1729.9 nmol/L) independently of the IL-6 dose administered, suggesting that the doses employed were at the top of the dose-response curve for these hormones. Interestingly, plasma arginine vasopressin (AVP) levels were also elevated during the 2 h after IL-6 injection in all patients who received a dose of 3 micrograms/kg or more, suggesting that IL-6 activated the magnocellular AVP-secreting neurons and that it might be involved in the syndrome of inappropriate AVP secretion. Cortisol elevations with peaks similar to those observed after the first injection of IL-6 were also detected in plasma sampled every 2 h after the second and third injections, suggesting that there was no rapid tachyphylaxis in response to IL-6 administration. Plasm…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504
Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF)
Akira, S., Hirano, T., Taga, T., & Kishimoto, T. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.11.2199284 · Cited by 1,306
Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans.
Mastorakos, G., Chrousos, G. P., & Weber, J. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263159 · Cited by 591
Self-citationAcute Hypothalamic–Pituitary–Adrenal Responses to the Stress of Treadmill Exercise
Luger, A., Deuster, P. A., Kyle, S. B., Gallucci, W. T., Montgomery, L. C., Gold, P. W., Loriaux, D. L., & Chrousos, G. P. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705213162105 · Cited by 516
Self-citationInterleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.
Kasahara, T., Hooks, J. J., Dougherty, S. F., & Oppenheim, J. J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1784 · Cited by 479
Naitoh, Y., Fukata, J., Tominaga, T., Nakai, Y., Tamai, S., Mori, K., & Imura, H. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81305-6 · Cited by 421
Perlstein, R. S., Whitnall, M. H., Abrams, J. S., Mougey, E. H., & Neta, R. (1993) · Endocrinology · doi:10.1210/en.132.3.946 · Cited by 257
BERNARDINI, R., KAMILARIS, T. C., CALOGERO, A. E., JOHNSON, E. O., GOMEZ, M. T., GOLD, P. W., & CHROUSOS, G. P. (1990) · Endocrinology · doi:10.1210/endo-126-6-2876 · Cited by 232
Self-citationPhase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.
Weber, J., Yang, J. C., Topalian, S. L., Parkinson, D. R., Schwartzentruber, D. S., Ettinghausen, S. E., Gunn, H., Mixon, A., Kim, H., & Cole, D. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.499 · Cited by 216
Self-citationSCHÜRMEYER, T. H., AVGERINOS, P. C., GOLD, P. W., GALLUCCI, W. T., TOMAI, T. P., CUTLER, G. B., LORIAUX, D. L., & CHROUSOS, G. P. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-6-1103 · Cited by 206
Self-citation
Cited by
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Self-citationEndocrinology of the stress response
Charmandari, E., Tsigos, C., & Chrousos, G. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.120816 · Cited by 1,799
Self-citationRegulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297
The Pathophysiologic Roles of Interleukin-6 in Human Disease
Papanicolaou, D. A., Wilder, R. L., Manolagas, S. C., & Chrousos, G. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-2-199801150-00009 · Cited by 1,146
“Because high doses of interleukin-6 increase plasma levels of vasopressin in humans (32), endogenous interleukin-6 may also participate in the pathogenesis of this syndrome.”
BackgroundSelf-citationCHROUSOS, G. P. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09006.x · Cited by 711
Self-citationImmune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection
Silverman, M. N., Pearce, B. D., Biron, C. A., & Miller, A. H. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.41 · Cited by 506
Haddad, J. J., Saadé, N. E., & Safieh-Garabedian, B. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00357-0 · Cited by 416
“Because IL-1 induces IL-6 in vivo, the extent to which IL-6 mediates the effects of IL-1 has come under investigation (Mastorakos et al., 1994).”
BackgroundAlesci, S., Martinez, P. E., Kelkar, S., Ilias, I., Ronsaville, D. S., Listwak, S. J., Ayala, A. R., Licinio, J., Gold, H. K., Kling, M. A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1667 · Cited by 372
Self-citationPediatric Stress: Hormonal Mediators and Human Development
Charmandari, E., Kino, T., Souvatzoglou, E., & Chrousos, G. P. (2003) · Hormone Research in Paediatrics · doi:10.1159/000069325 · Cited by 363
“Despite its inherent inflammatory activity, IL-6 plays a major role in the overall control of inflammation, by stimulating glucocorticoid secretion [”
BackgroundSelf-citationThe hypothalamic-pituitary-adrenal axis and the female reproductive system
MAGIAKOU, M. A., MASTORAKOS, G., WEBSTER, E., & CHROUSOS, G. P. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52128.x · Cited by 320
Self-citationCytokines: abnormalities in major depression and implications for pharmacological treatment
O'Brien, S. M., Scott, L. V., & Dinan, T. G. (2004) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.609 · Cited by 320
Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis
Beishuizen, A., & Thijs, L. G. (2003) · Journal of Endotoxin Research · doi:10.1179/096805103125001298 · Cited by 315
Exercise and the stress system.
Mastorakos, G. P., Pavlatou, M. G., Diamanti‐Kandarakis, E., & Chrousos, G. P. (2005) · PubMed · Cited by 380
Self-citationImmune variations in bipolar disorder: phasic differences
Ortiz‐Domínguez, A., Hernández, M. E., Berlanga, C., Gutiérrez‐Mora, D., Moreno, J., Heinze, G., & Pavón, L. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00493.x · Cited by 255
Hyponatremia and Inflammation: The Emerging Role of Interleukin-6 in Osmoregulation
Swart, R. M., Hoorn, E. J., Betjes, M. G., & Zietse, R. (2010) · Nephron Physiology · doi:10.1159/000322238 · Cited by 243
Crofford, L. J. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.4.1279 · Cited by 242
Self-citationObesity and adipokines: effects on sympathetic overactivity
Smith, M. M., & Minson, C. T. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.221036 · Cited by 237
“Evidence for IL-6 activating the HPA axis is provided by the appearance of adrenocorticotrophic releasing hormone (Mastorakos et al. 1994) and corticosterone (Lenczowski et al. 1999) following IL-6 administration.”
BackgroundStress: Endocrine Physiology and Pathophysiology
Tsigos, C., Kyrou, I., Kassi, E., & Chrousos, G. P. (2020) · PubMed · Cited by 302
Self-citationHigher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Yoshimura, R., Hori, H., Ikenouchi-Sugita, A., Umene-Nakano, W., Ueda, N., & Nakamura, J. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.03.020 · Cited by 227
Magiakou, M. A. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.5.1912 · Cited by 234
Self-citationPituitary Cytokine and Growth Factor Expression and Action
Ray, D., & Melmed, S. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.2.0297 · Cited by 220
“A number of the proinflammatory cytokines exert most, if not all, their activities at the hypothalamus, notably IL-6 acting on hypothalamic AVP (72), and IL-1 and TNF acting on CRH (40, 308).”
BackgroundInfluentialExercise-Associated Hyponatremia
Rosner, M. H., & Kirven, J. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02730806 · Cited by 215
“(68) demonstrated that IL-6 can act as an AVP”
BackgroundStress and the female reproductive system
Kalantaridou, S. N., Makrigiannakis, A., Zoumakis, E., & Chrousos, G. P. (2004) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2003.09.004 · Cited by 213
Self-citationCirculating levels of copeptin, a novel biomarker, in lower respiratory tract infections
Müller, B., Morgenthaler, N., Stolz, D., Schuetz, P., Müller, C., Bingisser, R., Bergmann, A., Tamm, M., & Christ‐Crain, M. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01762.x · Cited by 191
Päth, G., Bornstein, S. R., Ehrhart-Bornstein, M., & Scherbaum, W. A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4072 · Cited by 186
Role of vasopressin in the management of septic shock
Mutlu, G., & Factor, P. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2283-8 · Cited by 178
“interleukin-1b (IL-1b), IL-6, tumor necrosis-a] enhance vasopressin production [104, 105, 106].”
BackgroundDunlop, R. J., & Campbell, C. W. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00199-8 · Cited by 159
Ray, D. W., Ren, S. G., & Melmed, S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118615 · Cited by 158
“The LIF-related cytokine IL-6 has been shown to powerfully stimulate ACTH release in vivo (36), at least in part by a hypothalamic mechanism.”
BackgroundVallières, L., & Rivest, S. (1999) · Endocrinology · doi:10.1210/endo.140.9.6983 · Cited by 157
Hyponatremia in Marathon Runners due to Inappropriate Arginine Vasopressin Secretion
Siegel, A. J., Verbalis, J. G., Clement, S. C., Mendelson, J. H., Mello, N. K., Adner, M. M., Shirey, T., Glowacki, J., Lee-Lewandrowski, E., & Lewandrowski, K. B. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.10.027 · Cited by 159
Favalli, E. G. (2020) · Rheumatology and Therapy · doi:10.1007/s40744-020-00219-2 · Cited by 180
Pathophysiological Role of the Cytokine Network in the Anterior Pituitary Gland
ARZT, E. S., Páez-Pereda, M., Castro, C. P., Pagotto, U., Renner, U., & Stalla, G. K. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1998.0176 · Cited by 163
Raber, J. (1998) · Molecular Neurobiology · doi:10.1007/bf02741457 · Cited by 174
Hyponatremia and mortality risk: a Danish cohort study of 279 508 acutely hospitalized patients
Holland-Bill, L., Christiansen, C. F., Heide‐Jørgensen, U., Ulrichsen, S. P., Ring, T., Jørgensen, J. O. L., & Sørensen, H. T. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0111 · Cited by 150
Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management
Warren, A. M., Grossmann, M., Christ‐Crain, M., & Russell, N. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad010 · Cited by 184
The etiology of poststroke-depression: a hypothesis involving HPA axis
Zhou, L., Wang, T., Yu, Y., Li, M., Sun, X., Song, W., Wang, Y., Zhang, C., & Fu, F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113146 · Cited by 142
The Economic Burden of Hyponatremia: Systematic Review and Meta-Analysis
Corona, G., Giuliani, C., Parenti, G., Colombo, G. L., Sforza, A., Maggi, M., Forti, G., & Peri, A. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.03.007 · Cited by 119
Inflammation and hyponatremia: an underrecognized condition?
Park, S. J., & Shin, J. I. (2013) · Korean Journal of Pediatrics · doi:10.3345/kjp.2013.56.12.519 · Cited by 114
Ruiz-Sánchez, J. G., Nuñez-Gil, I. J., Cuesta, M., Rubio, M. Á., Maroun‐Eid, C., Arroyo‐Espliguero, R., Romero, R., Becerra‐Muñoz, V. M., Uribarri, A., Feltes, G. I., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.599255 · Cited by 107
Organization and Integration of the Endocrine System: The Arousal and Sleep Perspective
Chrousos, G. P. (2007) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2007.04.004 · Cited by 132
Self-citationRotondo, F., Butz, H., Syro, L. V., Yousef, G. M., Di Ieva, A., Restrepo, L. M., Quintanar-Stephano, A., Berczi, I., & Kovacs, K. (2016) · Pituitary · doi:10.1007/s11102-015-0703-0 · Cited by 93
“Following IL-6 injections, plasma AVP levels were noted to be elevated [83], and although it had no effect on mRNA expression, it did increase circulating ACTH and corticosterone levels [84] as well as PRL.”
BackgroundChikanza, I. C., Petrou, P., & Chrousos, G. P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05448.x · Cited by 100
Self-citationDiurnal Variations in the Human Host Response to Endotoxin
Pollmacher, T., Mullington, J., Korth, C., Schreiber, W., Hermann, D., Orth, A., Galanos, C., & Holsboer, F. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.1040 · Cited by 90
“and IL-6, both known to increase temperature and plasma Cortisol levels in humans [27-29], are likely to be important media-”
BackgroundChapter 7 Neuroendocrine–Immune Interactions in Teleost Fish
Kemenade, B. M. L. V.-V., Stolte, E. H., Metz, J. R., & Chadzińska, M. (2009) · Fish physiology · doi:10.1016/s1546-5098(09)28007-1 · Cited by 156
Management of Vasodilatory Shock: Defining the Role of Arginine Vasopressin
Dünser, M. W., Wenzel, V., Mayr, A. J., & Hasibeder, W. R. (2003) · Drugs · doi:10.2165/00003495-200363030-00001 · Cited by 101
Raber, J., O’Shea, R. D., Bloom, F. E., & Campbell, I. L. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-24-09473.1997 · Cited by 87
The hypothalamic–pituitary–adrenal axis in the pathogenesis of rheumatic diseases
Crofford, L. J. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00004-4 · Cited by 103
Dionysopoulou, S., Charmandari, E., Bargiota, Α., Vlahos, N., Mastorakos, G. P., & Valsamakis, G. (2021) · Nutrients · doi:10.3390/nu13020498 · Cited by 102
Self-citationHyponatremia in patients with infectious diseases
Liamis, G. L., Milionis, H. J., & Elisaf, M. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.07.013 · Cited by 85
Cole, C. L., Kleckner, I. R., Jatoi, A., Schwarz, E. M., & Dunne, R. F. (2018) · JCSM Clinical Reports · doi:10.17987/jcsm-cr.v3i2.65 · Cited by 104
“In fact, exogenous administration of IL‐1 [112], IL‐6 [113], TNF‐α [114], and IFN‐γ [115] result in an increase in plasma concentrations of cortisol in cancer patients [116] and healthy humans [117].”
BackgroundBenrick, A., Schéle, E., Pinnock, S. B., Wernstedt‐Asterholm, I., Dickson, S. L., Karlsson‐Lindahl, L., & Jansson, J. ‐. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01879.x · Cited by 79
Kakeda, S., Watanabe, K., Katsuki, A., Sugimoto, K., Igata, N., Ueda, I., Igata, R., Abe, O., Yoshimura, R., & Korogi, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-28300-5 · Cited by 78
Silverman, M. N., Miller, A. H., Biron, C. A., & Pearce, B. D. (2004) · Endocrinology · doi:10.1210/en.2003-1421 · Cited by 76
“In support of this notion, IL-6 production is increased in many clinical situations characterized by tissue injury and chronic inflammation (87), and long-term IL-6 administration in humans stimulates elevated levels of cortisol in the presence of low levels of ACTH (76, 88, 89).”
BackgroundThe role of interleukin‐6 in the human adrenal gland
Päth, G., Scherbaum, W. A., & Bornstein, S. R. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.0300s3091.x · Cited by 77
Circadian rhythm of salivary cortisol, plasma cortisol, and plasma ACTH in end-stage renal disease
Raff, H., & Trivedi, H. (2013) · Endocrine Connections · doi:10.1530/ec-12-0058 · Cited by 76
Neuroendocrine-immune interactions in teleost fish
Kemenade, B. M. L. V.-V., Stolte, E. H., Metz, J. R., & Chadzińska, M. (2009) · Cited by 74
Palin, K., Moreau, M. L., Sauvant, J., Orcel, H., Nadjar, A., Duvoid-Guillou, A., Dudit, J., Rabié, A., & Moos, F. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90489.2008 · Cited by 73
“other hand, IL-1 and IL-6 induced AVP release (29, 34, 39), and IL-1 stimulated the activity of AVP neurons (33).”
BackgroundExercise-Associated Hyponatremia: Role of Cytokines
Siegel, A. J. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.05.012 · Cited by 70
Functions of corticotropin‐releasing hormone in anthropoid primates: From brain to placenta
Power, M. L., & Schulkin, J. (2006) · American Journal of Human Biology · doi:10.1002/ajhb.20521 · Cited by 70
“…et al., 2001; Zoumakis et al., 2001), and to perform a number of key roles in inflammatory processes related to reproduction, such as ovulation (Mastorakos et al., 1994; Kalantaridou et al., 2004a), decidualization (Zoumakis et al., 2000), and implantation (Athanassakis et al., 1999; Karteris…”
BackgroundRECIPROCAL INTERACTIONS BETWEEN THE NEUROENDOCRINE AND IMMUNE SYSTEMS DURING INFLAMMATION
Chikanza, I. C., & Grossman, A. B. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70165-4 · Cited by 75
POMC‐Derived Peptides and Their Biological Action
Solomon, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08663.x · Cited by 74
Shimon, I., Yan, X., Ray, D. W., & Melmed, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119541 · Cited by 63
“In humans, subcutaneous or intravenous injection of IL-6 markedly increased ACTH and cortisol levels on the first day of cytokine administration (12–14), with no detectable change in circulating CRH concentrations that were close to the lower limit of assay detection (12, 14).”
BackgroundRummel, C., Inoue, W., Sachot, C., Poole, S., Hübschle, T., & Luheshi, G. N. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21850 · Cited by 66
“Similarly, IL-6 has been shown to increase AVP release after its systemic injection or during LPS-induced inflammation (Mastorakos et al., 1994; Palin et al., 2008).”
BackgroundKino, T., Rice, K. C., & Chrousos, G. P. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01796.x · Cited by 74
Self-citationGhorbel, M. T., Sharman, G., Leroux, M., Barrett, T., Donovan, D. M., Becker, K. G., & Murphy, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209902200 · Cited by 66
Yoshimura, R., Hori, H., Ikenouchi‐Sugita, A., Umene‐Nakano, W., Katsuki, A., Atake, K., & Nakamura, J. (2013) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2333 · Cited by 62
“In particular, it was suggested that IL-6 is involved in multiple physiological systems including the hypothalamic–pituitary–adrenal axis and in corticotrophinreleasing hormone activity at limbic sites, monoamine utilization, the release of oxidative stress, apoptotic pathways, and kinase signaling (Mastorakos et al.,…”
BackgroundDysfunction of the Hypothalamic-Pituitary-Adrenal axis in HIV infection and disease
Zapanti, E. D., Terzidis, K., & Chrousos, G. P. (2008) · HORMONES · doi:10.14310/horm.2002.1200 · Cited by 59
“In addition to their effects on the hypothalamus, cytokines can stimulate ACTH and cortisol release by acting directly on the pituitary and adrenals, respectively.(10,11) Other inflammatory mediators, like interferon-α, interferon-γ, interleukin-2, epidermal growth factor (EGF), transforming growth factor-β (TGF-β) an…”
BackgroundSelf-citationCostello, N. L., Bragdon, E. E., Light, K. C., Sigurdsson, A., Bunting, S., Grewen, K., & Maixner, W. (2002) · Pain · doi:10.1016/s0304-3959(02)00263-4 · Cited by 59
Persistent endocrine stress response in patients undergoing cardiac surgery
Roth-Isigkeit, A., Brechmann, J., DIBBELT, L., Sievers, H. H., Raasch, W., & Schmucker, P. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03347280 · Cited by 55
Fatouros, I. G., Chatzinikolaou, A., Paltoglou, G., Petridou, A., Avloniti, A. A., Jamurtas, A. Z., Goussetis, E., Mitrakou, A., Mougios, V., Lazaropoulou, C., et al. (2010) · Stress · doi:10.3109/10253891003743432 · Cited by 69
Self-citationVassilakopoulos, T., Zakynthinos, S. G., Roussos, C., & Economou), (. T. T. S. O. M. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.4.r1013 · Cited by 55
Adrenal cortical activation in murine colitis
Franchimont, D. P., Bouma, G., Galon, J., Wolkersdörfer, G. W., Haidan, A., Chrousos, G. P., & Bornstein, S. R. (2000) · Gastroenterology · doi:10.1053/gast.2000.20235 · Cited by 57
Self-citationSerum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome
Berni, A., Malandrino, D., Corona, G., Maggi, M., Parenti, G., Fibbi, B., Poggesi, L., Bartoloni, A., Lavorini, F., Fanelli, A., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1447 · Cited by 55
“Pro-inflammatory cytokines released by monocytes and macrophages, and particularly IL-6, are able to induce vasopressin secretion via two mechanisms: by a direct non-osmotic stimulation and by damaging alveolar basement membrane, which induces hypoxia, pulmonary vasoconstriction and vasopressin release (32-35).”
BackgroundHyponatremia and Syndrome of Inappropriate Antidiuretic Hormone Secretion in Kawasaki Disease
Lim, G.-W., Lee, M. A., Kim, H. S., et al. (2010) · Korean Circulation Journal · doi:10.4070/kcj.2010.40.10.507 · Cited by 51
Scroggins, S. M., Santillan, D. A., Lund, J. M., Sandgren, J. A., Krotz, L., Hamilton, W. S., Devor, E. J., Davis, H., Pierce, G. L., Gibson-Corley, K. N., et al. (2018) · Clinical Science · doi:10.1042/cs20171059 · Cited by 58
“Lastly, human cancer patients administered IL-6 had significantly higher circulating AVP levels within two hours of administration (69).”
BackgroundHew‐Butler, T. (2010) · Sports Medicine · doi:10.2165/11532070-000000000-00000 · Cited by 68
The effects of acute renal failure on drug metabolism
Philips, B. J., Lane, K., Dixon, J. J., & MacPhee, I. A. M. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.835802 · Cited by 49
“IL-6 activates the hypothalamic--pituitary--adrenal axis [99,100] increasing serum cortisol concentrations.”
BackgroundGryksa, K., & Neumann, I. D. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105601 · Cited by 55
Gionis, D., Ilias, I., Moustaki, M., Mantzos, E., Papadatos, I., Koutras, D. A., & Mastorakos, G. (2003) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2003.16.1.49 · Cited by 47
Self-citationNeuroendocrine immune responses to inflammation: the concept of the neuroendocrine immune loop
Chikanza, I. C., & Grossman, A. B. (1996) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(96)80015-x · Cited by 47
Fatty acid mixture counters stress changes in cortisol, cholesterol, and impair learning
Yehuda, S., Rabinovitz, S., Carasso, R. L., & Mostofsky, D. I. (2000) · International Journal of Neuroscience · doi:10.3109/00207450008986494 · Cited by 46
Wolkersdörfer, G. W., Lohmann, T., Marx, C., Schröder, S., Pfeiffer, R., Hd, S., Scherbaum, W. A., Chrousos, G. P., & Bornstein, S. R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6110 · Cited by 57
Self-citationValsamakis, G., Papatheodorou, D. C., Chalarakis, N., Vrachnis, N., Sidiropoulou, E. J., Manolikaki, M., Mantzou, A., Margeli, A., Papassotiriou, I., Chrousos, G. P., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.06.008 · Cited by 46
Self-citationGołyszny, M. J., Obuchowicz, E., & Zielinski, M. W. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102216 · Cited by 44
Papargyri, P., Zapanti, E. D., Salakos, N., Papargyris, L., Bargiota, Α., & Mastorakos, G. P. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1543585 · Cited by 43
“Indeed, in the past we have shown that administration of recombinant IL-6 to humans led to substantial increase of the AVP, ACTH, and GC peripheral concentrations [15,145,149,150].”
BackgroundSelf-citationGlucocorticoid withdrawal syndrome: what to expect and how to manage
Theiler‐Schwetz, V., & Prete, A. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000804 · Cited by 49
Roles of Reproductive Corticotropin‐Releasing Hormone
KALANTARIDOU, S. N., MAKRIGIANNAKIS, A., MASTORAKOS, G., & CHROUSOS, G. P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.015 · Cited by 40
Self-citationKageyama, K., Hanada, K., Iwasaki, Y., Sakihara, S., Nigawara, T., Kasckow, J., & Suda, T. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0125 · Cited by 43
“IL-6 is coexpressed with AVP in the SON and PVN neurons (Ghorbel et al. 2003) and also induces AVP secretion in the hypothalamus (Mastorakos et al. 1994).”
BackgroundVenlafaxine Hyponatraemia: Incidence, Mechanism and Management
Roxanas, M. G., Hibbert, E., & Field, M. J. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701261202 · Cited by 40
Cairns, R. S., & Hew-Butler, T. (2015) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000000144 · Cited by 37
“Research has demonstrated a positive correlation between IL-6 and AVP, with one study identifying IL-6 as a direct secretagogue for AVP.(28,29) Interleukin-6 levels increase dramatically in exercising humans with IL-6 being produced from exercising muscle rather than from circulating inflammatory cells.”
Influential(Far) Outside the box: Genomic approach to acute porphyria
Thunell, S. (2006) · Physiological Research · doi:10.33549/physiolres.930000.55.s2.43 · Cited by 50
Seasonal differences in rhythmicity of salivary cortisol in healthy adults
Kanikowska, D., Roszak, M., Rutkowski, R., Sato, M., Sikorska, D., Orzechowska, Z., Bręborowicz, A., & Witowski, J. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00972.2018 · Cited by 39
Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease?
Underwood, C. F., Hildreth, C. M., Wyse, B. F., Boyd, R. A., Goodchild, A. K., & Phillips, J. K. (2016) · Acta Physiologica · doi:10.1111/apha.12727 · Cited by 37
“Less clear is the role of central NO in the steady-state regulation of baroreflex function, with conflicting reports that central NO enhances (Jin & D’Alecy 1996, Ramchandra et al. 2014) or alternatively reduces (Matsumura et al. 1998) baroreflex control of heart rate and SNA.”
BackgroundPark, S. W., Shin, S. M., Jeong, M., Cho, D.-H., Lee, K. H., Eisenhut, M., Kronbichler, A., Moritz, M. L., & Shin, J. I. (2018) · Scientific Reports · doi:10.1038/s41598-018-34703-1 · Cited by 36
“23 2 hours after IL-6 injection in six patients.”
González‐Hernández, T., Afonso‐Oramas, D., Cruz‐Muros, I., Barroso‐Chinea, P., Abreu, P. M., Pérez-Delgado, M. D. M., Rancel‐Torres, N., & González, M. D. C. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6845.2005 · Cited by 35
Kalantaridou, S., Makrigiannakis, A., Zoumakis, E., & Chrousos, G. P. (2004) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2004.00155.x · Cited by 38
Self-citationYavropoulou, M. P., Filippa, M. G., Mantzou, A., Ntziora, F., Mylona, M., Tektonidou, M. G., Vlachogiannis, N. I., Paraskevis, D., Kaltsas, G. A., Chrousos, G. P., et al. (2022) · Endocrine · doi:10.1007/s12020-021-02968-8 · Cited by 33
Self-citationValdez-López, M., Aguirre-Aguilar, E., Valdés‐Ferrer, S. I., Martínez-Carrillo, F. M., Araúz, A., Barrera‐Vargas, A., & Merayo‐Chalico, J. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102739 · Cited by 39
Grinevich, V., Ma, X., Jirikowski, G. F., Verbalis, J. G., & Aguilera, G. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.00967.x · Cited by 34
Effects of the Immune/Inflammatory Reaction on the Hypothalamic‐Pituitary‐Adrenal Axis
Mastorakos, G. P., Magiakou, M. A., & Chrousos, G. P. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44700.x · Cited by 31
Self-citation
Metadata
- Authors
- Mastorakos, G., Weber, J. S., Magiakou, M. A., Gunn, H., & Chrousos, G. P.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1994-10
- Volume
- 79
- Issue
- 4
- Pages
- 934-939
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2068437805
- Cited by
- 290
- References
- 28
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 6 · 2023: 11 · 2022: 14 · 2021: 9 · 2020: 12 · 2019: 6 · 2018: 12 · 2017: 12 · 2016: 8 · 2015: 6 · 2014: 5 · 2013: 6 · 2012: 8
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- interleukin-6, hypothalamic-pituitary-adrenal axis, syndrome of inappropriate antidiuretic hormone secretion, ACTH, cortisol, magnocellular neurons, cytokine induction, tachyphylaxis, IL-1β, TNF-α, cancer patients, provocation tests, dose-response curves
- MeSH terms
- Adrenocorticotropic Hormone, Adult, Arginine Vasopressin, Circadian Rhythm, Corticotropin-Releasing Hormone, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Inappropriate ADH Syndrome, Male, Middle Aged, Recombinant Proteins, Interleukin-6, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.